Photo of Roxana Mehran

Roxana Mehran

  • PROFESSOR Medicine, Cardiology
  • PROFESSOR Population Health Science and Policy
Print ProfilePrint Profile



  • Interventional Cardiology

  • Cardiovascular Disease


  • MD, St. George's University

  • Residency, Internal Medicine
    Mount Sinai Hospital

  • Residency, Internal Medicine
    University of Connecticut

  • Fellowship, Cardiovascular Med
    Mount Sinai Hospital

  • Fellowship, Intervent Cardiology
    Mount Sinai Hospital


    Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI is Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine.  Dr. Mehran completed her training in internal medicine at the University of Connecticut, where she was also a Chief Medical Resident, before continuing with Fellowships in Cardiovascular Disease and Interventional Cardiology at Mount Sinai Medical Center. Dr. Mehran is internationally recognized for her work as a clinical trial specialist with complex data analyses and outcomes research within the field of interventional cardiology and for her experience and expertise in working with regulatory agencies to conduct clinical trials.   Her research interests expand from mechanisms of restenosis to treatment and prevention of acute kidney injury in cardiac patients, as well as advancing treatments for acute coronary syndromes and acute myocardial infarction.  In addition to founding a highly regarded academic research organization (ARO) within the Cardiovascular Research Foundation, she is also a widely published author and frequent invited speaker at national and international scientific conferences such as American Heart Association, American College of Cardiology, European Society of Cardiology, and EuroPCR.  She has served as Course Co-Director of the annual Transcatheter Cardiovascular Therapeutics (TCT) for the last 13 years.  Dr. Mehran serves on editorial board of multiple peer reviewed journals, including Journal of the American College of Cardiology, Circulation, and Circulation Research.  She currently serves on the board of trustees of SCAI, as a member of the Program Committee for the American Heart Association Scientific Sessions, as a member of the board of directors for Harboring Hearts, and as Program Chair for Society of Cardiac Angiography and Interventions (SCAI- WIN (Women in Innovations)) Initiative, and is also the Chief Scientific Officer of the Clinical Trials Center at the Cardiovascular Research Foundation (NYC).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Mehran during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • AstraZeneca; Bayer; CSL Behring; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Osprey Medical Inc.; Regado Biosciences, Inc.; The Medicines Company; Watermark Consulting

Scientific Advisory Board:

  • Abbott Laboratories; AstraZeneca; Boston Scientific Corporation; Covidien; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; The Medicines Company; sanofi-aventis

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

  • PlatformQ; sanofi-aventis

Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.

  • Covidien

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Claret¬†Medical Inc.¬†; Elixir Medical¬†Corporation

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central

Cardiocascular Medicine Associates

Guggenheim Pavilion
1190 Fifth Avenue - 1 South
New York, NY 10029

Tel: 212-659-9691
Fax: 646-537-8547
Get Directions

Office Hours:
  • Thursday 7:30am - 11:30am
  • Spanish
Insurance Plans
  • 1199 Member Choice
  • BCBS Direct POS
  • BCBS DirectShare POS
  • Beech Street
  • Empire Plan/UHC
  • Great West Insurance
  • HIP Commercial
  • HealthNet
  • Magnacare
  • Medicaid
  • Medicare
  • MultiPlan, Inc.
  • Oxford Freedom
  • Oxford Liberty
  • Pomco
  • United Health Care - Mount Sinai Top Tier
  • United Health Care Commercial
Payment Methods
  • Master Card
  • Discover
  • Cash